Skip to content
PICO Portalanswers from OpenAlex

Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i>

PaperCitations, authors & open-access status

Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i> is a paper indexed in PICO Portal from OpenAlex.

How many citations does Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i> have?

PICO Portalcitation count

Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i> has 191 citations in the OpenAlex counts PICO Portal stores.

When was Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i> published?

PICO Portalyear

Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i> has 2004 year in the PICO Portal index.

What is the open-access status of Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i>?

PICO Portaloa status

Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i> has closed oa status in the PICO Portal index.

What is the DOI of Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i>?

PICO Portaldoi

The DOI for Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i> is on the source record.

What is the PMID of Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i>?

PICO Portalpmid

The PMID for Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i> is on the source record.

What is the OpenAlex record for Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i>?

PICO Portalopenalex

The OpenAlex for Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i> is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial